SS

Savita Sandip Chaurasiya

Active Director Director DIN 06749478
DIN 06749478 First appointment Jan 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2014
Shareholding value •••• Premium profile

About Savita Sandip Chaurasiya

Data last updated:

Savita Sandip Chaurasiya is a Director at Delizia Pharmaceutical Private Limited (since 2014). The company operates in Pharma. Delizia Pharmaceutical Private Limited reported revenue of ₹51 Lakh (FY 2025).

DIN 06749478
Primary Designation Director
Industry Pharma
First Appointment 15 Jan 2014
Oldest Company Age 12 yrs
Largest company Delizia Pharmaceutical Private Limited · ₹51 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jan 20142014₹51 Lakh (FY 2025)Active

Board colleagues of Savita Sandip Chaurasiya

Directorship timeline

Open interactive timeline →
Delizia Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Savita Sandip Chaurasiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Savita Sandip Chaurasiya

Savita Sandip Chaurasiya currently holds 1 directorship: Delizia Pharmaceutical Private Limited (Director, since 15 Jan 2014, revenue ₹51 Lakh (FY 2025)).

Savita Sandip Chaurasiya was first appointed on 15 Jan 2014 as Director at Delizia Pharmaceutical Private Limited.

The current boards of Savita Sandip Chaurasiya's companies include Ganesh Bholanath Chaurasia (Delizia Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available